Clinical Trials
4 trialsNCT04836728 2025-03-13
CCICC-002b
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Active not recruiting
NCT06045767 2024-06-03
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer
Tel Aviv Medical Center
Phase 2 Not yet recruiting
NCT02117167 2024-01-10
SAFIR02_Lung
UNICANCER
Phase 2 Completed
NCT03656094 2019-12-09
Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors
Samsung Medical Center
Phase 2 Unknown